임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

18건 표시

1/2상완료· COVID-19 (Healthy Volunteers)
Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19)
리드: SK바이오사이언스
상세 →NCT04742738
1/2상완료· Non-Alcoholic Fatty Liver Disease
Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH
협력: 종근당
상세 →NCT04555434
1/2상완료· Carcinoma, Non-Small-Cell Lung
A Study of Lazertinib in Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
협력: 유한양행
상세 →NCT04075396
1/2상완료· Cervical Cancer
Immunogenicity and Safety Study of NBP615 in Healthy Female
리드: SK바이오사이언스
상세 →NCT04453241
1/2상완료· Metastatic Colorectal Cancer
A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination Chemotherapy
리드: GC녹십자
상세 →NCT03454620
1/2상완료· EGFR Gene Mutation
Clinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLC
리드: 유한양행
상세 →NCT03046992
1/2상완료· Recessive Dystrophic Epidermolysis Bullosa
Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB
협력: 대웅제약
상세 →NCT04520022
1/2상완료· Functional Constipation
Phase 1/2a Trial of YH12852 in Healthy Subjects and Patients With Functional Constipation
리드: 유한양행
상세 →NCT02538367
1/2상완료· Influenza
Safety, Tolerability, and Immunogenicity of GC3106 (Quadrivalent Cell-culture Based Influenza Vaccine)
리드: GC녹십자
상세 →NCT02249221
1/2상완료· Schizophrenia
A Safety, Tolerability, PK and PD Study of Multiple Oral Doses of SKL15508 in Subjects With Stable Schizophrenia
리드: SK바이오팜
상세 →NCT02205099
1/2상완료· Influenza
A Phase I/IIa Study of GC3110A (Quadrivalent Influenza Vaccine)
리드: GC녹십자
상세 →NCT02121782
1/2상완료· HER-2 Positive Advanced Gastric Cancer
A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer
리드: 한미약품
상세 →NCT01746771
1/2상완료· Degenerative Disc Disease
Safety, Tolerability and Efficacy of YH14618 in Patients With Degenerative Disc Disease
리드: 유한양행
상세 →NCT01526330
1/2상완료· Non Small Cell Lung Cancer
Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients
리드: 한미약품
상세 →NCT01588145
1/2상완료· Premature Ejaculation
Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044
리드: 유한양행
상세 →NCT01419470
1/2상완료· Mucopolysaccharidosis II
To Evaluate the Safety and Efficacy of GC1111 (Recombinant Human Iduronate-2-sulfatase) in Hunter Syndrome Patients
리드: GC녹십자
상세 →NCT01301898
1/2상완료· Influenza
Study to Evaluate the Safety and Immunogenicity of MG1109 in Healthy Adult Volunteers
리드: GC녹십자
상세 →NCT01389466
1/2상완료· Metastatic Breast Cancer
Evaluate Safety, Efficacy and Pharmacokinetics
리드: 셀트리온
상세 →NCT01084863

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.